LX-9211 Market Outlook 2026-2034 | Sales Forecast Highlights Emerging Commercial Opportunities
Lexicon Pharmaceuticals Inc LXRX
$1.80
▼ -3.49%
($-0.07)
⬇️ Below Yest. Low
Open
$1.87
Prev Close
$1.86
Day Range
$1.77 – $1.93
52W Range
$1.10 – $2.68
Market Cap
$798.70M
Beta
1.05
EPS (TTM)
$-0.15
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-04-07 |
| Shares Out. | 444,200,000 |
| Website | lexpharma.com/ ↗ |
| Phone | 12818633000 |
| Employees | 81 |
| Revenue | $692,000 |
| Gross Profit | $653,000 |
| Net Income | -$31.8M |
| Free Cash Flow | -$65.0M |
| Total Assets | $250.1M |
| Total Liabilities | $75.5M |
| Equity | $174.5M |
About Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Lexicon Pharmaceuticals Inc is a publicly traded company under the ticker symbol LXRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-09-01)